Target intelligence / Profile preview

Reactive oxygen species and transition metal ions (ROS and metal ions)

Target
ROS and metal ions
Molecular classification
Small molecules, Inorganic ions, Reactive intermediates, Other
01

Overview

Reactive oxygen species (ROS) and transition metal ions, primarily iron and copper, are chemical entities that collectively modulate the cellular redox environment and drive oxidative stress. ROS are oxygen-derived molecules, such as superoxide and hydrogen peroxide, that are produced as natural byproducts of oxygen metabolism and function as secondary messengers in signal transduction (Sies et al., 2017, Nature Reviews Molecular Cell Biology). Transition metal ions act as potent catalysts that facilitate the Fenton and Haber-Weiss reactions, converting relatively stable ROS into the highly toxic hydroxyl radical, which causes irreversible damage to lipids, proteins, and DNA (Halliwell & Gutteridge, 2015, Free Radicals in Biology and Medicine). This synergistic interaction is a central mechanism in the pathogenesis of neurodegenerative diseases like Alzheimer's and Parkinson's, and it is the defining driver of ferroptosis, a form of regulated cell death (Dixon et al., 2012, Cell). Therapeutic strategies targeting these species involve the use of chelating agents to sequester metal ions and antioxidants to scavenge ROS, thereby preventing oxidative damage and preserving cellular integrity.

Other names
Oxidative stress mediatorsFenton reactantsPro-oxidant speciesRedox-active metals and oxygen radicals
02

Mechanism of action

Chelation of transition metal ions to prevent the catalytic formation of hydroxyl radicals and direct scavenging of reactive oxygen species to mitigate oxidative damage to cellular components.

03

Biological functions

Redox signalingCell deathOxidative stress inductionImmune responseSignal transduction
04

Disease associations

Neurodegenerative diseaseCancerCardiovascular diseaseInflammationIschemia-reperfusion injury
05

Safety considerations

Systemic depletion of essential trace metalsDisruption of physiological redox signaling pathwaysPotential pro-oxidant effects of antioxidants at high concentrationsToxicity of metal-chelator complexes
06

Interacting drugs

Deferoxamine

8 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)8-IsoprostaneProtein carbonylsGlutathione/Glutathione disulfide ratio (GSH/GSSG)

Beyond the preview

Go deeper on Reactive oxygen species and transition metal ions (ROS and metal ions).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and transition metal ions (ROS and metal ions).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call